Jacquie Andreano represents clients in all facets of commercial litigation. Prior to joining Keker, Van Nest & Peters, Jacquie served as a law clerk to Judge Christina Reiss in the District of Vermont. She earned her J.D. from the University of California, Berkeley, School of Law and her B.A. in English and Philosophy from the University of Alabama. While in law school Jacquie served as a domestic violence unit law clerk with the San Francisco District Attorney's Office and as the Editor in Chief of the Berkeley Journal of Gender, Law, and Justice.
We defended Dexcom in the District of Delaware where Abbott asserted a dozen patents targeting Dexcom’s G6 continuous glucose monitoring technology. The Keker team narrowed the case to four patents prior to trial, including by invalidating an Abbott patent at summary judgment, and excluded Abbott’s expert testimony regarding reasonable royalty damages. Following a two-week trial, the jury invalidated another Abbott patent and found two were not infringed. The Court also declined to let the Jury consider damages on the remaining patent, cementing a defense victory for the Keker trial team.
Keker, Van Nest & Peters partners Bob Van Nest, Sharif Jacob, Sophie Hood and Ryan Wong reflect on the firm’s biggest trial wins which earned its place among Law360’s 2024 Trials Groups of the Year. Read more
Law360 has reported that a Delaware federal jury has cleared Dexcom, represented by Keker, Van Nest & Peters, of infringing two glucose monitor patents owned by an Abbott Laboratories unit, while finding infringement of one that was not willful. It hung on a fourth. The trial was overseen by Third Circuit Judge Kent A. Jordan in the U.S. District of Delaware, who decided a second trial will be held to determine any damages. Read more
The Disproportionate Effect of Mutual Restraining Orders on Same-Sex Domestic Violence Victims 108 Calif. L. Rev. (June 2020)